Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Leukemia

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 160 articles: HTML format Text format

Single Articles

March 2010
1. MCCLUNE BL , Weisdorf DJ, Pedersen TL, da Silva GT, et al
   Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. RAVANDI F , Cortes JE, Jones D, Faderl S, et al
   Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. BRANDALISE SR , Pinheiro VR, Aguiar SS, Matsuda EI, et al
   Benefits of the Intermittent Use of 6-Mercaptopurine and Methotrexate in Maintenance Treatment for Low-Risk Acute Lymphoblastic Leukemia in Children: Randomized Trial From the Brazilian Childhood Cooperative Group--Protocol ALL-99.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. ROBAK T , Jamroziak K, Gora-Tybor J, Stella-Holowiecka B, et al
   Comparison of Cladribine Plus Cyclophosphamide With Fludarabine Plus Cyclophosphamide As First-Line Therapy for Chronic Lymphocytic Leukemia: A Phase III Randomized Study by the Polish Adult Leukemia Group (PALG-CLL3 Study).
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. GOLDMAN JM , Majhail NS, Klein JP, Wang Z, et al
   Relapse and Late Mortality in 5-Year Survivors of Myeloablative Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia in First Chronic Phase.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. WIERDA WG , Kipps TJ, Mayer J, Stilgenbauer S, et al
   Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. LEUNG R , Lopes D, Lam C, Wong KF, et al
   Diffuse Osteosclerosis Complicating Hairy Cell Leukemia.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles   
   
   
   
8. ROBAK T , Dmoszynska A, Solal-Celigny P, Warzocha K, et al
   Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. LANEUVILLE P , Dilea C, Yin OQ, Woodman RC, et al
   Comparative In Vitro Cellular Data Alone Are Insufficient to Predict Clinical Responses and Guide the Choice of BCR-ABL Inhibitor for Treating Imatinib-Resistant Chronic Myeloid Leukemia.
   J Clin Oncol. 2010.
   PubMed     Text format     Related articles   
   
   
   February 2010
10. YAMAMOTO K , Utsunomiya A, Tobinai K, Tsukasaki K, et al
    Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. WALTER RB , Kantarjian HM, Huang X, Pierce SA, et al
    Effect of Complete Remission and Responses Less Than Complete Remission on Survival in Acute Myeloid Leukemia: A Combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M.D. Anderson Cancer Center Study.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. QUINTAS-CARDAMA A , Wierda W, O'Brien S
    Investigational immunotherapeutics for B-cell malignancies.
    J Clin Oncol. 2010;28:884-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. BURCHERT A , Muller MC, Kostrewa P, Erben P, et al
    Sustained Molecular Response With Interferon Alfa Maintenance After Induction Therapy With Imatinib Plus Interferon Alfa in Patients With Chronic Myeloid Leukemia.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
14. FILANOVSKY K , Shvidel L, Shtalrid M
    Advantage of MIDAM Protocol in Treatment of the Elderly Patients With Refractory and Relapsing Acute Myeloid Leukemia.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
15. RUBNITZ JE , Inaba H, Ribeiro RC, Pounds S, et al
    NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. GORE SD , Gojo I, Sekeres MA, Morris L, et al
    Single Cycle of Arsenic Trioxide-Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. VERNERIS MR , Grupp SA
    Natural Killer Cell Consolidation for Acute Myelogenous Leukemia: A Cell Therapy Ready for Prime Time?
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
18. PAUTAS C , Merabet F, Thomas X, Raffoux E, et al
    Randomized Study of Intensified Anthracycline Doses for Induction and Recombinant Interleukin-2 for Maintenance in Patients With Acute Myeloid Leukemia Age 50 to 70 Years: Results of the ALFA-9801 Study.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
19. DUFOUR A , Schneider F, Metzeler KH, Hoster E, et al
    Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. BURNETT AK , Hills RK, Milligan DW, Goldstone AH, et al
    Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. DAMM F , Heuser M, Morgan M, Yun H, et al
    Single Nucleotide Polymorphism in the Mutational Hotspot of WT1 Predicts a Favorable Outcome in Patients With Cytogenetically Normal Acute Myeloid Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. KANTARJIAN HM , Erba HP, Claxton D, Arellano M, et al
    Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults With Acute Myeloid Leukemia and Unfavorable Prognostic Factors.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. FENAUX P , Mufti GJ, Hellstrom-Lindberg E, Santini V, et al
    Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. CASHEN AF , Schiller GJ, O'Donnell MR, Dipersio JF, et al
    Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. SCHILLER GJ , O'Brien SM, Pigneux A, Deangelo DJ, et al
    Single-Agent Laromustine, A Novel Alkylating Agent, Has Significant Activity in Older Patients With Previously Untreated Poor-Risk Acute Myeloid Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. BECKER H , Marcucci G, Maharry K, Radmacher MD, et al
    Favorable Prognostic Impact of NPM1 Mutations in Older Patients With Cytogenetically Normal De Novo Acute Myeloid Leukemia and Associated Gene- and MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. SCHIFFER CA
    "I Am Older, Not Elderly," Said the Patient With Acute Myeloid Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
28. LIM Z , Brand R, Martino R, van Biezen A, et al
    Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. HARTLEY MA , Tao J, Baz R
    Merkel Cell Carcinoma in the Peripheral Blood of a Patient With Concomitant Chronic Lymphocytic Leukemia and Multiple Myeloma.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
30. BOURNE AE , Wayment RO, Tarter TH, Hemmer P, et al
    Isolated Relapse of Acute Lymphoblastic Leukemia in the Epididymis: A Rare Sanctuary Site.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
31. CORTES JE , Baccarani M, Guilhot F, Druker BJ, et al
    Phase III, Randomized, Open-Label Study of Daily Imatinimb Mesylate 400 mg Versus 800 mg in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase Using Molecular End Points: Tyrosine Kinase Inhibitor Optimizatio
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. CORTES JE , Jones D, O'Brien S, Jabbour E, et al
    Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. CORTES JE , Jones D, O'Brien S, Jabbour E, et al
    Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. GOLDMAN JM
    Chronic Myeloid Leukemia: Reversing the Chronic Phase.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    November 2009
35. MENON R , Twardowski P, Forman SJ, Huang Q, et al
    Primary Gonadal Germ Cell Tumor Associated With Acute Leukemia With Common Cytogenetics.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
36. NAGAI S , Takahashi T, Kurokawa M
    Risk-Adapted Maintenance Therapy for Acute Promyelocytic Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
37. SINGHAL MK , Krishnan V, Singh S, Kumar R, et al
    Isolated Ovarian Relapse in a 68-Year-Old Woman With Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
38. KANTARJIAN H , Garcia-Manero G, O'Brien S, Faderl S, et al
    Phase I Clinical and Pharmacokinetic Study of Oral Sapacitabine in Patients With Acute Leukemia and Myelodysplastic Syndrome.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. CHOI ER , Ko YH, Kim SJ, Jang JH, et al
    Gastric Recurrence of Extramedullary Granulocytic Sarcoma After Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
40. SOHANI AR , Ferry JA, Chang PS, Abramson JS, et al
    Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma During Therapy With Alemtuzumab for T-Cell Prolymphocytic Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
41. GOLDSBY RE , Liu Q, Nathan PC, Bowers DC, et al
    Late-Occurring Neurologic Sequelae in Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. ZAREIFAR S , Bordbar MR, Karim M, Geramizadeh B, et al
    T-Cell Lymphoblastic Lymphoma of the Sternum.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
43. VEDY D , Muehlematter D, Rausch T, Stalder M, et al
    Acute Myeloid Leukemia With Myeloid Sarcoma and Eosinophilia: Prolonged Remission and Molecular Response to Imatinib.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
44. KADAN-LOTTICK NS , Brouwers P, Breiger D, Kaleita T, et al
    Comparison of Neurocognitive Functioning in Children Previously Randomly Assigned to Intrathecal Methotrexate Compared With Triple Intrathecal Therapy for the Treatment of Childhood Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. KAKIMOTO T , Nakazato T, Hayashi R, Hayashi H, et al
    Bilateral Occipital Lobe Invasion in Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
46. BACCARANI M , Cortes J, Pane F, Niederwieser D, et al
    Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
47. RAO AV , Valk PJ, Metzeler KH, R Acharya C, et al
    Age-Specific Differences in Oncogenic Pathway Dysregulation and Anthracycline Sensitivity in Patients With Acute Myeloid Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. KO RH , Ji L, Barnette P, Bostrom B, et al
    Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. NAGAI S , Takahashi T, Kurokawa M
    How Should We Prevent Hematologic Relapse of Acute Promyelocytic Leukemia?
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
50. MANDELLI F , Vignetti M, Suciu S, Stasi R, et al
    Daunorubicin Versus Mitoxantrone Versus Idarubicin as Induction and Consolidation Chemotherapy for Adults With Acute Myeloid Leukemia: The EORTC and GIMEMA Groups Study AML-10.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. LIN TS , Ruppert AS, Johnson AJ, Fischer B, et al
    Phase II Study of Flavopiridol in Relapsed Chronic Lymphocytic Leukemia Demonstrating High Response Rates in Genetically High-Risk Disease.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. ENNISHI D , Maeda Y, Niiya M, Shinagawa K, et al
    Incidental Detection of Acute Lymphoblastic Leukemia on [18F]Fluorodeoxyglucose Positron Emission Tomography.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
53. BASSO G , Veltroni M, Valsecchi MG, Dworzak MN, et al
    Risk of Relapse of Childhood Acute Lymphoblastic Leukemia Is Predicted By Flow Cytometric Measurement of Residual Disease on Day 15 Bone Marrow.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. NACHMAN JB , La MK, Hunger SP, Heerema NA, et al
    Young Adults With Acute Lymphoblastic Leukemia Have an Excellent Outcome With Chemotherapy Alone and Benefit From Intensive Postinduction Treatment: A Report From the Children's Oncology Group.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. SCHULTZ KR , Bowman WP, Aledo A, Slayton WB, et al
    Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. PUI CH
    Toward a Total Cure for Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    September 2009
57. MARTINELLI G , Iacobucci I, Storlazzi CT, Vignetti M, et al
    IKZF1 (Ikaros) Deletions in BCR-ABL1-Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. TIU RV , Gondek LP, O'Keefe CL, Huh J, et al
    New Lesions Detected by Single Nucleotide Polymorphism Array-Based Chromosomal Analysis Have Important Clinical Impact in Acute Myeloid Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. METZELER KH , Dufour A, Benthaus T, Hummel M, et al
    ERG Expression Is an Independent Prognostic Factor and Allows Refined Risk Stratification in Cytogenetically Normal Acute Myeloid Leukemia: A Comprehensive Analysis of ERG, MN1, and BAALC Transcript Levels Using Oligonucleotide Microarrays.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. CILLONI D , Renneville A, Hermitte F, Hills RK, et al
    Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. BENEKLI M , Baumann H, Wetzler M
    Targeting signal transducer and activator of transcription signaling pathway in leukemias.
    J Clin Oncol. 2009;27:4422-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. O'BRIEN S , Moore JO, Boyd TE, Larratt LM, et al
    5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
63. CORTES JE , Kantarjian HM, Goldberg SL, Powell BL, et al
    High-Dose Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: High Rates of Rapid Cytogenetic and Molecular Responses.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. PREBET T , Boissel N, Reutenauer S, Thomas X, et al
    Acute Myeloid Leukemia With Translocation (8;21) or Inversion (16) in Elderly Patients Treated With Conventional Chemotherapy: A Collaborative Study of the French CBF-AML Intergroup.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. BOSCH F , Abrisqueta P, Villamor N, Terol MJ, et al
    Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone a New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. PORTUGAL RD , Garnica M, Nucci M
    Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve.
    J Clin Oncol. 2009;27:3849-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. SHEIKH SI , Stemmer-Rachamimov A, Attar EC
    Autopsy diagnosis of progressive multifocal leukoencephalopathy with JC virus-negative CSF after cord blood stem-cell transplantation.
    J Clin Oncol. 2009;27:e46-7.
    PubMed     Text format     Related articles   
    
    
    
68. JEHA S , Razzouk B, Rytting M, Rheingold S, et al
    Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. KNAUF WU , Lissichkov T, Aldaoud A, Liberati A, et al
    Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. RINGDEN O , Labopin M, Ehninger G, Niederwieser D, et al
    Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. SCHIMMER AD , Estey EH, Borthakur G, Carter BZ, et al
    Phase I/II Trial of AEG35156 X-Linked Inhibitor of Apoptosis Protein Antisense Oligonucleotide Combined With Idarubicin and Cytarabine in Patients With Relapsed or Primary Refractory Acute Myeloid Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. HUGHES T , Saglio G, Branford S, Soverini S, et al
    Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in Patients With Chronic Myeloid Leukemia in Chronic Phase.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
73. MANSOUR MR , Sulis ML, Duke V, Foroni L, et al
    Prognostic Implications of NOTCH1 and FBXW7 Mutations in Adults With T-Cell Acute Lymphoblastic Leukemia Treated on the MRC UKALLXII/ECOG E2993 Protocol.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. TSUKIMOTO I , Tawa A, Horibe K, Tabuchi K, et al
    Risk-Stratified Therapy and the Intensive Use of Cytarabine Improves the Outcome in Childhood Acute Myeloid Leukemia: The AML99 Trial From the Japanese Childhood AML Cooperative Study Group.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. SHANAFELT TD , Kay NE, Rabe KG, Call TG, et al
    Brief Report: Natural History of Individuals With Clinically Recognized Monoclonal B-Cell Lymphocytosis Compared With Patients With Rai 0 Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. GORIN NC , Labopin M, Blaise D, Reiffers J, et al
    Higher Incidence of Relapse With Peripheral Blood Rather Than Marrow As a Source of Stem Cells in Adults With Acute Myelocytic Leukemia Autografted During the First Remission.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. STILGENBAUER S , Zenz T, Winkler D, Buhler A, et al
    Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocytic Leukemia Study Group.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. TOMBLYN MB , Arora M, Baker KS, Blazar BR, et al
    Myeloablative Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia: Analysis of Graft Sources and Long-Term Outcome.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. GO RS
    Smudge Cells, Serum Albumin, and Prognosis in B-Cell Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    June 2009
80. OEFFINGER KC , Adams-Huet B, Victor RG, Church TS, et al
    Insulin Resistance and Risk Factors for Cardiovascular Disease in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. COUSTAN-SMITH E , Sandlund JT, Perkins SL, Chen H, et al
    Minimal Disseminated Disease in Childhood T-Cell Lymphoblastic Lymphoma: A Report From the Children's Oncology Group.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. ZHANG WW , Cortes JE, Yao H, Zhang L, et al
    Predictors of Primary Imatinib Resistance in Chronic Myelogenous Leukemia Are Distinct From Those in Secondary Imatinib Resistance.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. GRIMWADE D , Jovanovic JV, Hills RK, Nugent EA, et al
    Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. APPERLEY JF , Cortes JE, Kim DW, Roy L, et al
    Dasatinib in the Treatment of Chronic Myeloid Leukemia in Accelerated Phase After Imatinib Failure: The START A Trial.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. KANTARJIAN HM , Shan J, Jones D, O'Brien S, et al
    Significance of Increasing Levels of Minimal Residual Disease in Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia in Complete Cytogenetic Response.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. TRAN B , Fong C, Tong M, Hosking P, et al
    Malignant Melanoma Mimicking Acute Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
87. STEENSMA DP
    The Blood of the Lamb.
    J Clin Oncol. 2009;27:2729-31.
    PubMed     Text format     Related articles   
    
    
    May 2009
88. SHANAFELT TD , Call TG, Zent CS, Laplant B, et al
    Phase I Trial of Daily Oral Polyphenon E in Patients With Asymptomatic Rai Stage 0 to II Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. LANGER C , Marcucci G, Holland KB, Radmacher MD, et al
    Prognostic Importance of MN1 Transcript Levels, and Biologic Insights From MN1-Associated Gene and MicroRNA Expression Signatures in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. BURKHARDT B , Reiter A, Landmann E, Lang P, et al
    Poor Outcome for Children and Adolescents With Progressive Disease or Relapse of Lymphoblastic Lymphoma: A Report From the Berlin-Frankfurt-Muenster Group.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. ZELTZER LK , Recklitis C, Buchbinder D, Zebrack B, et al
    Psychological status in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.
    J Clin Oncol. 2009;27:2396-404.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. KELAIDI C , Chevret S, De Botton S, Raffoux E, et al
    Improved Outcome of Acute Promyelocytic Leukemia With High WBC Counts Over the Last 15 Years: The European APL Group Experience.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. KREITMAN RJ , Stetler-Stevenson M, Margulies I, Noel P, et al
    Phase II Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With Hairy Cell Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
94. KRAUTER J , Wagner K, Schafer I, Marschalek R, et al
    Prognostic Factors in Adult Patients up to 60 Years Old With Acute Myeloid Leukemia and Translocations of Chromosome Band 11q23: Individual Patient Data-Based Meta-Analysis of the German Acute Myeloid Leukemia Intergroup.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
95. HWANG YY , Leung AY, Ng IO, Chan GS, et al
    Protein Losing Enteropathy Due to T-Cell Large Granular Lymphocyte Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
96. KRISTINSSON SY , Derolf AR, Edgren G, Dickman PW, et al
    Socioeconomic Differences in Patient Survival Are Increasing for Acute Myeloid Leukemia and Multiple Myeloma in Sweden.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. BERTAGNOLLI MM , Niedzwiecki D, Compton CC, Hahn HP, et al
    Microsatellite Instability Predicts Improves Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. MEDEIROS BC
    Role of CEBPA in Normal Karyotype Acute Myeloid Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    
99. NOWAKOWSKI GS , Hoyer JD, Shanafelt TD, Zent CS, et al
    Percentage of Smudge Cells on Routine Blood Smear Predicts Survival in Chronic Lymphocytic Leukemia.
    J Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
100. WIERDA WG , O'Brien S, Wang X, Faderl S, et al
     Characteristics Associated With Important Clinical End Points in Patients With Chronic Lymphocytic Leukemia at Initial Treatment.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. ARORA M , Weisdorf DJ, Spellman SR, Haagenson MD, et al
     HLA-Identical Sibling Compared With 8/8 Matched and Mismatched Unrelated Donor Bone Marrow Transplant for Chronic Phase Chronic Myeloid Leukemia.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. DELLA PORTA MG , Malcovati L, Boveri E, Travaglino E, et al
     Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.
     J Clin Oncol. 2009;27:754-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. KOSCHMIEDER S , Halmos B, Levantini E, Tenen DG, et al
     Dysregulation of the C/EBPalpha differentiation pathway in human cancer.
     J Clin Oncol. 2009;27:619-28.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
104. ROMAN-GOMEZ J , Agirre X, Jimenez-Velasco A, Arqueros V, et al
     Epigenetic Regulation of MicroRNAs in Acute Lymphoblastic Leukemia.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. REDAELLI S , Piazza R, Rostagno R, Magistroni V, et al
     Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants.
     J Clin Oncol. 2009;27:469-71.
     PubMed     Text format     Related articles   
     
     
     
106. FREIREICH EJ , Kurzrock R
     The role of investigational therapy in management of patients with advanced metastatic malignancy.
     J Clin Oncol. 2009;27:304-6.
     PubMed     Text format     Related articles   
     
     
     
107. CHAKRABORTY S , Sun CL, Francisco L, Sabado M, et al
     Accelerated Telomere Shortening Precedes Development of Therapy-Related Myelodysplasia or Acute Myelogenous Leukemia After Autologous Transplantation for Lymphoma.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. HUGUET F , Leguay T, Raffoux E, Thomas X, et al
     Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. HEWAMANA S , Lin TT, Rowntree C, Karunanithi K, et al
     Rel A Is an Independent Biomarker of Clinical Outcome in Chronic Lymphocytic Leukemia.
     J Clin Oncol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
110. TSIMBERIDOU AM , Wen S, McLaughlin P, O'Brien S, et al
     Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. FOLLO MY , Finelli C, Clissa C, Mongiorgi S, et al
     Phosphoinositide-Phospholipase C {beta}1 Mono-Allelic Deletion Is Associated With Myelodysplastic Syndromes Evolution Into Acute Myeloid Leukemia.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. LAMANNA N , Jurcic JG, Noy A, Maslak P, et al
     Sequential Therapy With Fludarabine, High-Dose Cyclophosphamide, and Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia Produces High-Quality Responses: Molecular Remissions Predict for Durable Complete Responses.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. FOON KA , Boyiadzis M, Land SR, Marks S, et al
     Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. RAVANDI F , Estey E, Jones D, Faderl S, et al
     Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. AHMADI T , Schuster SJ
     Variations on the Fludarabine, Cyclophosphamide, and Rituximab Combination in Chronic Lymphocytic Leukemia Therapy: What Have We Learned?
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
116. MEDEIROS BC
     Comparing Apples and Oranges in Normal Karyotype Acute Myeloid Leukemia.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
117. LELEU X , Soumerai J, Roccaro A, Hatjiharissi E, et al
     Increased Incidence of Transformation and Myelodysplasia/Acute Leukemia in Patients With Waldenstrom Macroglobulinemia Treated With Nucleoside Analogs.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. BADER P , Kreyenberg H, Henze GH, Eckert C, et al
     Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. TSUKASAKI K , Hermine O, Bazarbachi A, Ratner L, et al
     Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. GOLDMAN JM
     Chronic Myeloid Leukemia Stem Cells: Now on the Run.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
121. RODRIGUES CA , Sanz G, Brunstein CG, Sanz J, et al
     Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. BUCHNER T , Berdel WE, Haferlach C, Haferlach T, et al
     Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. KILBRIDGE TM , Kadin ME
     Teenager With Hairy Cell Leukemia: 30-Year Follow-Up.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     November 2008
124. HOTTA K , Kiura K, Takigawa N, Matsuo K, et al
     Paradoxical Clinical Effects of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Acute Myelogenous Leukemia.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
125. OBEROI SS , Abou Jawde RM
     Is Alemtuzumab Really the Single Active Agent for Treatment of Chronic Lymphocytic Leukemia?
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
126. HAHN T , McCarthy PL Jr, Zhang MJ, Wang D, et al
     Risk Factors for Acute Graft-Versus-Host Disease After Human Leukocyte Antigen-Identical Sibling Transplants for Adults With Leukemia.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
127. HORAN JT , Alonzo TA, Lyman GH, Gerbing RB, et al
     Impact of Disease Risk on Efficacy of Matched Related Bone Marrow Transplantation for Pediatric Acute Myeloid Leukemia: The Children's Oncology Group.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. GARDNER A , Mattiuzzi G, Faderl S, Borthakur G, et al
     Randomized Comparison of Cooked and Noncooked Diets in Patients Undergoing Remission Induction Therapy for Acute Myeloid Leukemia.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. HEINRICH MC , Owzar K, Corless CL, Hollis D, et al
     Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology G
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. CHEVALLIER P , Mohty M, Lioure B, Michel G, et al
     Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC.
     J Clin Oncol. 2008;26:4940-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. CHEVALLIER P , Delaunay J, Turlure P, Pigneux A, et al
     Long-Term Disease-Free Survival After Gemtuzumab, Intermediate-Dose Cytarabine, and Mitoxantrone in Patients With CD33+ Primary Resistant or Relapsed Acute Myeloid Leukemia.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. LAURENTI L , Tarnani M, Innocenti I, Savino G, et al
     Chronic Lymphocytic Leukemia With Eyelid Involvement Responding to Alemtuzumab.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
133. BRAHMANDAY GR , Gheorghe G, Jaiyesimi IA, Orazi A, et al
     Primary mediastinal germ cell tumor evolving into an extramedullary acute megakaryoblastic leukemia causing cord compression.
     J Clin Oncol. 2008;26:4686-8.
     PubMed     Text format     Related articles   
     
     
     
134. GARMEY EG , Liu Q, Sklar CA, Meacham LR, et al
     Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
     J Clin Oncol. 2008;26:4639-45.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
135. STRAUSS GM , Herndon JE 2nd, Maddaus MA, Johnstone DW, et al
     Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non-Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. MARCUCCI G , Maharry K, Radmacher MD, Mrozek K, et al
     Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With, CEBPA Mutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. BHOJWANI D , Kang H, Menezes RX, Yang W, et al
     Gene Expression Signatures Predictive of Early Response and Outcome in High-Risk Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study on Behalf of the Dutch Childhood Oncology Group and the German Cooperative Study Group for Childhoo
     J Clin Oncol. 2008;26:4376-84.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. PASSARIN MG , Vattemi E, Musso AM, Romito S, et al
     Intracranial granulocytic sarcoma after chemotherapy for pineal germinoma and testicular cancer.
     J Clin Oncol. 2008;26:4507-9.
     PubMed     Text format     Related articles   
     
     
     
139. SIKIC BI , Tibshirani R, Lacayo NJ
     Genomics of childhood leukemias: the virtue of complexity.
     J Clin Oncol. 2008;26:4367-8.
     PubMed     Text format     Related articles   
     
     
     
140. SORROR ML , Storer BE, Sandmaier BM, Maris M, et al
     Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. GRIBBEN JG
     Role of Allogeneic Hematopoietic Stem-Cell Transplantation in Chronic Lymphocytic Leukemia.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
142. BUNIN NJ , Davies SM, Aplenc R, Camitta BM, et al
     Unrelated donor bone marrow transplantation for children with acute myeloid leukemia beyond first remission or refractory to chemotherapy.
     J Clin Oncol. 2008;26:4326-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. CHANAN-KHAN AA , Whitworth A, Bangia N, Porter CW, et al
     Lenalidomide-Associated Tumor Flare Reaction Is Manageable in Patients With Chronic Lymphocytic Leukemia.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles   
     
     
     
144. SCHETELIG J , Bornhauser M, Schmid C, Hertenstein B, et al
     Matched Unrelated or Matched Sibling Donors Result in Comparable Survival After Allogeneic Stem-Cell Transplantation in Elderly Patients With Acute Myeloid Leukemia: A Report From the Cooperative German Transplant Study Group.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. PABST T , Eyholzer M, Haefliger S, Schardt J, et al
     Somatic CEBPA Mutations Are a Frequent Second Event in Families With Germline CEBPA Mutations and Familial Acute Myeloid Leukemia.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. MEYERHARDT JA , Niedzwiecki D, Hollis D, Saltz LB, et al
     Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.
     J Clin Oncol. 2008;26:4109-15.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
147. AZIM HA JR , Gigli F, Martinelli G, Peccatori FA, et al
     Extramedullary myeloid sarcoma of the breast.
     J Clin Oncol. 2008;26:4041-3.
     PubMed     Text format     Related articles   
     
     
     
148. THOMPSON CA
     The difficult patient.
     J Clin Oncol. 2008;26:4035-6.
     PubMed     Text format     Related articles   
     
     
     
149. RAETZ EA , Borowitz MJ, Devidas M, Linda SB, et al
     Reinduction platform for children with first marrow relapse in acute lymphoblastic lymphoma.
     J Clin Oncol. 2008;26:3971-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. SCHETELIG J , van Biezen A, Brand R, Caballero D, et al
     Allogeneic Hematopoietic Stem-Cell Transplantation for Chronic Lymphocytic Leukemia With 17p Deletion: A Retrospective European Group for Blood and Marrow Transplantation Analysis.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. BREEMS DA , Van Putten WL, De Greef GE, Van Zelderen-Bhola SL, et al
     Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. KESARI S , Akar S, Saad A, Drappatz J, et al
     Progressive multifocal leukoencephalopathy in a patient with relapsed acute myelogenous leukemia.
     J Clin Oncol. 2008;26:3804-7.
     PubMed     Text format     Related articles   
     
     
     
153. RAETZ EA , Cairo MS, Borowitz MJ, Blaney SM, et al
     Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study.
     J Clin Oncol. 2008;26:3756-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
154. CALIGARIS-CAPPIO F , Ghia P
     Novel Insights in Chronic Lymphocytic Leukemia: Are We Getting Closer to Understanding the Pathogenesis of the Disease?
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. KHORASHAD JS , de Lavallade H, Apperley JF, Milojkovic D, et al
     Finding of Kinase Domain Mutations in Patients With Chronic Phase Chronic Myeloid Leukemia Responding to Imatinib May Identify Those at High Risk of Disease Progression.
     J Clin Oncol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. PITINI V , Arrigo C, Altavilla G
     Erlotinib in a patient with acute myelogenous leukemia and concomitant non-small-cell lung cancer.
     J Clin Oncol. 2008;26:3645-6.
     PubMed     Text format     Related articles   
     
     
     
157. VAUGHAN WP , Karp JE
     The long road to a cure for acute myelocytic leukemia: from intensity to specificity.
     J Clin Oncol. 2008;26:3475-7.
     PubMed     Text format     Related articles   
     
     
     
158. JADERSTEN M , Malcovati L, Dybedal I, Della Porta MG, et al
     Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome.
     J Clin Oncol. 2008;26:3607-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. ANDERSON LA , Pfeiffer RM, Rapkin JS, Gridley G, et al
     Survival Patterns Among Lymphoma Patients With a Family History of Lymphoma.
     J Clin Oncol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. BLOOM SH
     In defense of futile gestures.
     J Clin Oncol. 2008;26:3276-8.
     PubMed     Text format     Related articles   
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: